Table 1 Characteristics of study sample at baseline
Characteristics | Â | Â | N |
|---|---|---|---|
Age (years) | Mean (SD) | 84.1 (7.5) | 579 |
Women | N (%) | 374 (64.3) | 582 |
Single as marital status | N (%) | 389 (67.7) | 582 |
GMHR | |||
 Poor | N (%) | 60 (10.8) | 557 |
 Fair | N (%) | 220 (39.5) | 557 |
 Good | N (%) | 250 (44.9) | 557 |
 Excellent | N (%) | 27 (4.8) | 557 |
CDR-SoB | Mean (SD) | 11.2 (3.6) | 575 |
Type of dementia | |||
 AD | N (%) | 414 (71.0) | 582 |
 VAD | N (%) | 46 (7.9) | 582 |
 FTD | N (%) | 47 (8.1) | 582 |
 LBD/PD | N (%) | 22 (3.8) | 582 |
 AD/VAD | N (%) | 11 (1.9) | 582 |
 Unspecified | N (%) | 42 (7.2) | 582 |
NPI-NH | |||
 Agitation sub-syndrome | Mean (SD) | 4.5 (7.3) | 561 |
 Psychosis sub-syndrome | Mean (SD) | 1.9 (4.2) | 560 |
 Affective disorders sub-syndrome | Mean (SD) | 3.9 (5.9) | 572 |
 Apathy | Mean (SD) | 1.3 (2.7) | 570 |
Use of psychotropic medication | |||
 Antipsychotics | N (%) | 71 (12.2) | 582 |
 Antidepressants | N (%) | 167 (28.7) | 582 |
 Anxiolytics | N (%) | 89 (15.3) | 582 |
 Hypnotics/Sedatives | N (%) | 128 (22.0) | 582 |
 Anti-dementia medication | N (%) | 163 (28.0) | 582 |
NH characteristics | |||
 RU | N (%) | 367 (63.1) | 582 |
 SCU | N (%) | 215 (36.9) | 582 |